AFREZZA is BACK!

AFREZZA is BACK!

Afrezza is BACK!  After Sanofi terminated its marketing partnership with MannKind, MannKind has relaunched its fast-acting inhalable insulin, Afrezza, as reported in DiaTribe.org on 30 August, 2016.  I, for one, couldn’t be happier and more relieved.    ...
Skip to content